DOJ Reportedly Prepping Lawsuit To Block UnitedHealth Group-Amedisys Deal

The Department of Justice is reportedly prepping a lawsuit to block UnitedHealth Group’s (NYSE: UNH) takeover of Amedisys (Nasdaq: AMED). Bloomberg first reported the news. Its report, citing anonymous sources, says that the Amedisys and UnitedHealth Group leaders did meet with DOJ officials last week. That meeting did not change the DOJ’s mind, however. UnitedHealth […]

DOJ Reportedly Delays Lawsuit Decision On UnitedHealth Group-Amedisys Deal

Amedisys (Nasdaq: AMED) and UnitedHealth Group (NYSE: UNH) leaders were reportedly set to meet with officials from the U.S. Department of Justice (DOJ) this week over their pending deal. The DOJ’s decision on whether to file a lawsuit to block the deal, however, has now reportedly been postponed until after the Nov. 5 presidential election. […]

UnitedHealth Group, Amedisys Set For All-Important Meeting With DOJ Officials

UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) leaders are reportedly expected to meet with officials from the Department of Justice over the next week to discuss their pending deal. The companies will likely make a final case for why the deal should go through, while the DOJ considers whether to officially file a lawsuit […]

Facing Headwinds, UnitedHealth Group Remains Focused On Value-Based Care

The Centers for Medicare & Medicaid Services’ (CMS) Medicare rate cuts, state-driven Medicaid member redeterminations and the Change Healthcare cyberattack. These are just three disruptions that UnitedHealth Group’s (NYSE: UNH) leadership has had to factor in when setting future growth objectives. “It’s a distinctive part of the culture of UnitedHealth Group that we continue to […]

State Scrutiny Of UnitedHealth Group-Amedisys Deal Pushes Timeline Back Further 

UnitedHealth Group’s (NYSE:UNH) acquisition of Amedisys (Nasdaq:AMED) is still pending. That could be due to a variety of factors, but one is clear: the Oregon Health Authority’s (OHA) ongoing review, which is expected to continue until at least the end of November. OHA’s Health Care Market Oversight (HCMO) program reviews health care business deals to […]

More Home Health Providers Sunset Relationships With Largest Medicare Advantage Payers

Essentia Health – a regional, nonprofit health system with a substantial home health arm – announced this week that it will no longer serve as an in-network provider for UnitedHealth Group (NYSE: UNH) and Humana Inc. (NYSE: HUM) Medicare Advantage (MA) plans. It is the latest example of home-focused health care providers drawing a line […]

What Comes Next After Enhabit’s UnitedHealthcare Contract Termination

Enhabit Inc. (NYSE: EHAB) CEO Barb Jacobsmeyer said Wednesday that the company would terminate its contract with the country’s largest Medicare Advantage (MA) payer, UnitedHealth Group’s (NYSE UNH) UnitedHealthcare. UnitedHealthcare accounts for 9.4 million MA beneficiaries, or 29% of all enrollees, according to the Kaiser Family Foundation. Humana Inc. (NYSE: HUM), which is the second-largest […]

Amedisys’ High-Acuity, Non-Medicare Revenue Skyrockets As It Waits For UnitedHealth Group Deal To Close

Amedisys Inc. (Nasdaq: AMED) is waiting for multiple big-time transactions to come to fruition by year end. In the meantime, it continues to grow its non-Medicare revenue and its high-acuity care business considerably. The company released its second-quarter earnings on Wednesday, without an accompanying call. It has not held an official earnings call since UnitedHealth […]